Galecto Announces Plans to Explore Strategic Alternatives
BOSTON, Sept. 26, 2023 -- Galecto, Inc. , a clinical-stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that it has completed a...
Source: marketscreener.com